BORMANN-KENNEDY BARBARA-JEAN ANNE
SEC Form 4 insider trading activity
BORMANN-KENNEDY BARBARA-JEAN ANNE has filed 2 SEC Form 4 filings (3 transaction rows) across 1 company, with disclosures dating back to 2025. 2 of those filings fall inside the rolling window. Most recent filing: Jun 5, 2026.
On the most recent filing, BORMANN-KENNEDY BARBARA-JEAN ANNE is listed as Director at Xeris Biopharma Holdings, Inc. Inside the rolling window, BORMANN-KENNEDY BARBARA-JEAN ANNE reported no open-market purchases and 2 open-market sales totaling $204K in XERS. The largest disclosed transaction in the window is a sale of 15,000 XERS shares on Dec 12, 2025, worth $106K.
Companies traded
Other insiders at XERS
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$204K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has BORMANN-KENNEDY BARBARA-JEAN ANNE made?
BORMANN-KENNEDY BARBARA-JEAN ANNE has filed 2 SEC Form 4 filings (3 transaction rows) across 1 company since 2025.
Which companies does BORMANN-KENNEDY BARBARA-JEAN ANNE trade?
BORMANN-KENNEDY BARBARA-JEAN ANNE has filed SEC Form 4 disclosures for 1 company, including XERS.
When was BORMANN-KENNEDY BARBARA-JEAN ANNE's most recent SEC Form 4 filing?
BORMANN-KENNEDY BARBARA-JEAN ANNE's most recent SEC Form 4 filing on Tracefour is dated Jun 5, 2026.
What is BORMANN-KENNEDY BARBARA-JEAN ANNE's total buy and sell value in the current window?
Inside the rolling retention window, BORMANN-KENNEDY BARBARA-JEAN ANNE bought $0 and sold $204K based on SEC Form 4 filings.
What was BORMANN-KENNEDY BARBARA-JEAN ANNE's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 15,000 XERS shares on 2025-12-12, worth $106K, per SEC Form 4 filings.